Vienna psychiatrist says Long COVID care must include the brain
A Medical University of Vienna psychiatrist is arguing that Long COVID treatment is too narrow when it ignores neuropsychiatric symptoms like brain fog, fatigue and sleep disruption. The case comes alongside new research and an interview published Nov. 17, 2026, focused on evidence-based care for Long COVID and other post-acute infection syndromes.
Why it matters: - Long COVID affects more than one organ system, and Dr. Lucie Bartova says care that excludes the brain is “artificial and clinically unhelpful.” - The argument matters for patients whose symptoms include cognitive problems, sleep disturbance, pain, sensory overload and emotional exhaustion. - Bartova’s work is aimed at building evidence-based treatments for the neuropsychiatric symptoms of Long COVID and related post-acute infection syndromes.
What happened: - Dr. Lucie Bartova, a senior consultant in psychiatry and psychotherapeutic medicine at the Medical University of Vienna, was featured in a Rising Star interview published Nov. 17, 2026, in Psychedelics: The Journal of Psychedelic and Psychoactive Drug Research. - The interview is titled “Lucie Bartova: Beyond Treatment Resistance: Personalized Psychiatry, Brain Recovery, and the Human Behind the Diagnosis.” - The interview appears in Genomic Press’s Innovators and Ideas series, which profiles scientific researchers and their work. - The interview is freely available through open access here. - More information on the series is available at the interview website.
The details: - Bartova is deputy head of a specialized outpatient clinic for treatment-resistant depression at the Medical University of Vienna. - She also heads a special outpatient unit for pharmacogenetics, which studies how genes shape a patient’s response to medication. - In 2023, Bartova co-edited a Frontiers in Psychiatry research collection with Sherry-Anne Muscat and Glenn Hartelius on ketamine in psychiatric disorders. - Bartova said Long COVID is a multisystem disease with relevant brain involvement. - She said patients should not have to identify as psychiatrically ill in order to benefit from psychiatric expertise. - She described symptoms seen in Long COVID patients as familiar to psychiatry, including depression, anxiety, trauma-related conditions and ADHD. - She said psychiatry already has therapeutic tools that can often improve these symptoms. - Bartova said strict boundaries between psychiatry, neurology, internal medicine, immunology and cardiology are often artificial in complex multisystem illness. - Her clinical approach is to assess symptoms carefully, translate them into neurobiological and systemic mechanisms, and then build a treatment strategy. - She said she wants to challenge categorical thinking in medicine. - In treatment-resistant depression, Bartova said a review of prior care often shows underdosing, treatment that ended too soon, or missed diagnoses such as anxiety disorders, substance use disorders, ADHD or somatic conditions. - She said some cases that look like depression may instead reflect autoimmune or neurological disease. - For patients with true treatment resistance, Bartova listed tranylcypromine, lithium augmentation, (es)ketamine, electroconvulsive therapy, vagus nerve stimulation and clinical trials of novel approaches. - Bartova said rapid-acting agents such as ketamine and esketamine suggest the treatment options for the most severely ill patients are still expanding. - She said treatment resistance is not only pharmacological, but also diagnostic, biological, psychological and human. - She said explanation matters as much as prescription, and that some patients stop essential medication because nobody explained its purpose clearly enough. - Bartova said she wants patients to become experts in their own illness.
Between the lines: - Bartova’s view pushes against a narrow organ-by-organ model of medicine and favors a more integrated approach to complex illness. - Her comments also reframe some “treatment-resistant” depression as a problem of incomplete diagnosis or incomplete care, not just failed drugs. - The interview places psychiatry inside the Long COVID conversation at a time when many patients still struggle to get symptoms taken seriously. - Her emphasis on explanation and patient understanding suggests adherence problems may be partly communication problems, not only clinical ones.
What’s next: - Bartova says her research is focused on developing evidence-based treatment approaches for Long COVID-related neuropsychiatric symptoms. - The open-access interview may help broaden discussion among clinicians working on post-acute infection syndromes and treatment-resistant depression. - The Genomic Press series will continue highlighting researchers whose work blends clinical science with personal perspective.
The bottom line: - Bartova’s message is blunt: Long COVID care is incomplete if it ignores the brain, and psychiatry may have more to offer than many patients have been told.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Science Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.